# K972881: Ces Vascular Occlusion System

- Pathway: 510(k) (Traditional)
- Applicant: Cordis Neurovascular, Inc.
- Decided: Jun 4, 1998 after 303 days
- Product code: HCG (Device, Neurovascular Embolization)
- Device class: 2
- Regulation: 21 CFR 882.5950
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 2 generations back to K891688 (1989). 6 ancestors in all.
79 later devices descend from it; 2 cite it directly.
1 of 86 devices in its family (counting itself) has a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K964367: Ces Vascular Occlusion System, Cordis Neurovascular, Inc. (1997) Summary page 1.
- K913312: Helix Shaped Coils with Dacron Fibers, Modified, Target Therapeutics (1991) Summary page 1.
- K901337: Hilal Embolization Microcoil (TM), Cook, Inc. (1990) Summary page 1.

## Most influential descendants
- K983483: Vascular Occlusion System (1999), 78 descendants of its own
- K993455: Flipper Detachable Embolization Coil (2000), 41 descendants of its own
- K031810: Amplatzer Vascular Plug (2003), 38 descendants of its own
- K071962: Vascular Occlusion System (Trufill Pushable Coils and Trupush Coil Pusher) (2007), 32 descendants of its own
- K073442: Micrus Microcoil Systems (2008), 31 descendants of its own

## Indications for use
CES Pushable Coils may be used to obstruct or reduce the rate of blood flow in vessels of the neurovasculature for the interventional management of arteriovenous malformations, arteriovenous fistulas and other vascular lesions of the brain, spinal cord, and spine.

Source page: https://510kreport.com/device/K972881
Methodology: https://510kreport.com/methodology